Ginkgo Bioworks Holdings Inc
NYSE:DNA
Ginkgo Bioworks Holdings Inc
NYSE:DNA
Price:
0.8611 USD
2.26%
Market Closed
Updated:
May 3, 2024
Ginkgo Bioworks Holdings Inc
Operating Income
|
Ginkgo Bioworks Holdings Inc
Operating Income Peer Comparison
Comparables:
SHW
IFF
DD
ECL
PPG
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
Operating Income
-$576m
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Operating Income
$3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Operating Income
$578m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Operating Income
$1.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Operating Income
$2.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Operating Income
$2.3B
|
CAGR 3-Years
11%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
See Also
What is Ginkgo Bioworks Holdings Inc's Operating Income?
Operating Income
-576m
USD
-576m
USD
Based on the financial report for Dec 31, 2023, Ginkgo Bioworks Holdings Inc's Operating Income amounts to -576m USD.
What is Ginkgo Bioworks Holdings Inc's Operating Income growth rate?
Operating Income CAGR 3Y
-61%
-61%
Over the last year, the Operating Income growth was 73%. The average annual Operating Income growth rates for Ginkgo Bioworks Holdings Inc have been -61% over the past three years .
You don't have any saved screeners yet
